Does EMAPALUMAB Cause Leukocytosis? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Leukocytosis have been filed in association with EMAPALUMAB (GAMIFANT). This represents 5.2% of all adverse event reports for EMAPALUMAB.
9
Reports of Leukocytosis with EMAPALUMAB
5.2%
of all EMAPALUMAB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Leukocytosis From EMAPALUMAB?
Of the 9 reports, 8 (88.9%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Leukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EMAPALUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does EMAPALUMAB Cause?
Off label use (67)
Condition aggravated (37)
Drug ineffective (37)
Haemophagocytic lymphohistiocytosis (33)
Multiple organ dysfunction syndrome (22)
Staphylococcal bacteraemia (17)
Adrenal insufficiency (14)
Drug reaction with eosinophilia and systemic symptoms (14)
Respiratory failure (14)
Pyrexia (12)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which EMAPALUMAB Alternatives Have Lower Leukocytosis Risk?
EMAPALUMAB vs EMAPALUMAB-LZSG
EMAPALUMAB vs EMEND
EMAPALUMAB vs EMICIZUMAB
EMAPALUMAB vs EMICIZUMAB-KXWH
EMAPALUMAB vs EMPAGLIFLOZIN